Hong Kong Construction Stock News

SEHK:2333
SEHK:2333Auto

Great Wall Motor (SEHK:2333) Pushes Into Europe As Valuation Questions Come Into Focus

Great Wall Motor (SEHK:2333) has laid out an international expansion plan, targeting a 3% to 5% share of the European car market by 2030. The plan is anchored by the Ora 5 urban SUV launch. See our latest analysis for Great Wall Motor. Great Wall Motor's HK$8.85 share price has seen a sharp short term pullback, with the 30 day share price return down 15.47% and the year to date share price return down 41.47%. The 3 year total shareholder return of 7.40% contrasts with a 26.33% decline over...
SEHK:16
SEHK:16Real Estate

Sun Hung Kai Properties (SEHK:16) Lands A Major Data Centre Customer, Is The Stock Still Cheap?

Sun Hung Kai Properties (SEHK:16) drew attention after its technology arm SUNeVision secured a major new customer for the MEGA IDC facility, with Phase One occupancy expected to increase from 30% to about 70% and later phases to be accelerated. See our latest analysis for Sun Hung Kai Properties. Recent trading reflects that this SUNeVision contract has arrived during a mixed period for Sun Hung Kai Properties, with the share price at HK$115.3, a 1-day share price return of 1.86%, a...
SEHK:2588
SEHK:2588Trade Distributors

Is BOC Aviation (SEHK:2588) A Bargain Following Its Qatar Airways Leaseback Deal?

Event overview: Qatar Airways sale and leaseback deal BOC Aviation (SEHK:2588) drew fresh attention after announcing agreements to purchase three Airbus A350-1000 aircraft from Qatar Airways and lease them back under long term arrangements. The aircraft were delivered in late 2025, and the company classifies the deal as a Qualified Aircraft Leasing Activity and a discloseable transaction under Hong Kong listing rules, which underscores its relevance within sector norms. See our latest...
SEHK:3808
SEHK:3808Machinery

Sinotruk (Hong Kong) (SEHK:3808) Approves Final Dividend As Valuation Questions Persist

Sinotruk (Hong Kong) (SEHK:3808) shareholders approved a final dividend at the 29 June 2026 AGM, offering either HK$0.88 or CN¥0.78 per share for the year ended 31 December 2025. See our latest analysis for Sinotruk (Hong Kong). The dividend decision comes as Sinotruk (Hong Kong)'s share price has risen strongly over the year, with a year to date share price return of 49.32%, while the 1 year total shareholder return of 83.71% and 5 year total shareholder return of 276.36% indicate momentum...
SEHK:9637
SEHK:9637Pharmaceuticals

Alebund Pharmaceuticals Jiangsu (SEHK:9637) Jumps After IPO But Is The Valuation Already Priced In

Alebund Pharmaceuticals (Jiangsu) (SEHK:9637) has just completed a HK$1.28b IPO in Hong Kong, an event that brings new attention to its kidney disease drug pipeline and newly listed H shares. See our latest analysis for Alebund Pharmaceuticals (Jiangsu). The strong first day reception for Alebund Pharmaceuticals (Jiangsu) has been followed by a 1 day share price return of 18.75% to HK$30.28, although the share price return year to date is down 34.17%. This suggests short term momentum is...
SEHK:9999
SEHK:9999Entertainment

NetEase (SEHK:9999) Could Be 35% Undervalued As Earnings Beat Estimates

What changed at NetEase and why it matters for shareholders NetEase (SEHK:9999) recently approved a Third Amended and Restated Memorandum and Articles of Association at its 2026 Annual General Meeting, a governance update that helps frame how investors may view the stock’s latest move. The bylaw changes came shortly after NetEase stock gained 7.32% over the past week, following quarterly earnings of HK$4.03 per share versus an estimated HK$3.42, a 17.77% difference that has drawn fresh...
SEHK:788
SEHK:788Telecom

Is China Tower (SEHK:788) A Bargain After Its GSMA Move And AI Network Upgrade?

GSMA membership and AI focused network upgrade reshape the China Tower story China Tower (SEHK:788) has joined the GSMA and completed a nationwide upgrade that turns 5.6 million base stations and 2.1 million tower sites into intelligent edge computing hubs for connectivity in the AI era. See our latest analysis for China Tower. Despite the AI focused upgrade and GSMA membership, China Tower’s recent share price momentum has softened, with the stock at HK$9.04 and the 1 month share price...
SEHK:267
SEHK:267Industrials

Is CITIC (SEHK:267) Undervalued Following Its Final Dividend Announcement?

CITIC (SEHK:267) drew investor attention after its 26 June 2026 AGM, where the company declared a 2025 final dividend of RMB 0.385 per share, payable in either RMB or Hong Kong dollars. See our latest analysis for CITIC. While the 2025 final dividend announcement has focused attention on income, CITIC’s 1 month share price return is down 20.98% and the year to date share price return is down 13%, even as the 5 year total shareholder return of 83.56% points to a much stronger long term...
SEHK:2171
SEHK:2171Biotechs

CARsgen Therapeutics (SEHK:2171) Is Up 20.8% After First Solid Tumor CAR T Approval - What's Changed

CARsgen Therapeutics Holdings announced that China’s National Medical Products Administration has approved satricabtagene autoleucel (satri-cel), an autologous Claudin18.2-targeted CAR T-cell therapy, for Claudin18.2-positive, HER2-negative advanced gastric/gastroesophageal junction adenocarcinoma in patients who have failed at least two prior treatments. As the first CAR T-cell therapy approved globally for solid tumors, satri-cel could reshape treatment options in high-burden cancers like...